No Data
CRMI: Annual Report 2024
Express News | China Regenerative Medicine International - Yan Shibin Will Be Appointed as CFO
There's No Escaping China Regenerative Medicine International Limited's (HKG:8158) Muted Revenues Despite A 31% Share Price Rise
CRMI: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024
CRMI (08158): KPMG has been appointed as the new auditor.
CRMI (08158) announced that on January 6, 2025, Zhongzheng Tianheng Accounting Firm will...
CRMI (08158.HK) signed a leasing agreement with Positron.
Grace Covenant, November 1st - China Regenerative Medicine (08158.HK) announced that on November 1, 2024, the company's wholly owned subsidiary HKIRC and CRMI (Hong Kong) (as tenant) entered into a lease agreement with independent third party Zhengxin (as landlord), accordingly, Zhengxin agreed to lease the property to the company.
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 25% Pounding
